脑膜血管外皮细胞瘤病例报告:从脑到脊髓的9年历程
本文报告一例46岁男性2008年因疑似左侧顶枕部大脑镰脑膜瘤行手术,9年后出现胸椎转移灶并致顽固性疼痛,复查颅脑病理将原诊断更正为脑膜血管外皮细胞瘤(HPC),术后确认脊柱病灶为转移瘤。作者指出文献缺乏随机对照试验及大样本研究界定HPC自然史,整块切除联合放疗似乎可提供最佳的无病生存。
要点
- 脑膜血管外皮细胞瘤(HPC)较脑膜瘤切除后局部复发风险更高,远处转移率可达23%。
- 颅内HPC转移至椎骨非常罕见,文献迄今仅报告9例。
- 作者指出整块切除联合放疗似乎可提供最佳的无病生存。
核心结论
- 文献缺乏随机对照试验及大样本研究界定HPC自然史以给出精确管理的明确推荐。
- 整块切除联合放疗似乎可提供最佳的无病生存。
研究设计与样本
- 病例报告:1例46岁男性,2008年因疑似左侧顶枕部大脑镰脑膜瘤行手术,9年后出现胸椎转移灶。
主要发现
- 患者9年后出现胸椎肿块并导致顽固性疼痛。
- 复查颅脑病理将2008年诊断更正为脑膜血管外皮细胞瘤(HPC)。
- 脊柱病灶术后确认转移瘤。
- HPC较脑膜瘤切除后局部复发风险更高,远处转移可达23%。
- 颅内HPC转移至椎骨非常罕见,文献迄今仅报告9例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemangiopericytomas (HPCs) are rare and aggressive vascular mesenchymal tumors. Unlike meningiomas, which have a similar radiologic appearance, these tumors have a higher risk of local recurrence after resection, and distant metastasis can reach up to 23%. Metastases to the vertebral bones from an intracranial HPC are very rare, with so far only 9 cases reported in the literature. CASE DESCRIPTION: We present the case of a 46-year-old man who was surgically treated for a presumed left parieto-occipital falx meningioma in 2008. He presented 9 years later with a thoracic vertebral mass that was causing relentless pain. Reexamination of the cranial pathology allowed correction of the diagnosis performed in 2008 to a meningeal HPC, and the spinal lesion was confirmed after surgery to be a metastatic tumor. CONCLUSIONS: The literature lacks randomized controlled trials and large studies defining the natural history of HPC to draw clear recommendations for a precise management of the disease. However, en bloc resection followed by radiation therapy seems to provide the optimal treatment for a long disease-free survival.
引用
- Sweid A, Noureldine MHA, Nasser S, et al. A Case Report of Meningeal Hemangiopericytoma: A 9-Year Journey from the Brain to the Spine. World Neurosurg. 2018. PMID: 30447454. doi:10.1016/j.wneu.2018.11.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。